We are live on ! Find out more
CIM

CIM Investment Management Portfolio holdings

AUM $375M
1-Year Est. Return 32.03%
This Fund
S&P 500
This Quarter Est. Return
+6.51%
1 Year Est. Return
+32.03%
3 Year Est. Return
+88.62%
5 Year Est. Return
+95.83%
10 Year Est. Return
+334.77%
AUM
$338M
AUM Growth
+$13.9M
Cap. Flow
-$2.76M
Cap. Flow %
-0.82%
Top 10 Hldgs %
48.08%
Holding
267
New
12
Increased
5
Reduced
159
Closed
13

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.2M
2
AKAM icon
Akamai
AKAM
+$1.16M
3
SBUX icon
Starbucks
SBUX
+$986K
4
NEM icon
Newmont
NEM
+$961K
5
TGT icon
Target
TGT
+$861K

Top Sells

Rank Stock Value
1
TYL icon
Tyler Technologies
TYL
+$1.07M
2
HCA icon
HCA Healthcare
HCA
+$818K
3
GS icon
Goldman Sachs
GS
+$812K
4
MMM icon
3M
MMM
+$755K
5
LMT icon
Lockheed Martin
LMT
+$674K

Sector Composition

Rank Sector Weight
1 Technology 20.37%
2 Consumer Discretionary 7.19%
3 Healthcare 6.99%
4 Industrials 6.6%
5 Communication Services 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRM icon
101
Salesforce
CRM
$161B
$634K 0.19%
2,316
-82
-3% -$21K
LHX icon
102
L3Harris
LHX
$53.7B
$626K 0.19%
2,631
-47
-2% -$10.9K
HON icon
103
Honeywell
HON
$74.6B
$612K 0.18%
3,142
-57
-2% -$11.1K
OXY icon
104
Occidental Petroleum
OXY
$59.3B
$611K 0.18%
11,850
-393
-3% -$22.4K
EQT icon
105
EQT Corp
EQT
$34B
$607K 0.18%
16,580
-294
-2% -$10K
ABT icon
106
Abbott
ABT
$190B
$601K 0.18%
5,274
-176
-3% -$19.3K
ZG icon
107
Zillow
ZG
$7.85B
$586K 0.17%
9,456
-427
-4% -$22.2K
WST icon
108
West Pharmaceutical
WST
$24.7B
$580K 0.17%
1,932
-60
-3% -$18.4K
ZTS icon
109
Zoetis
ZTS
$31B
$568K 0.17%
2,907
-83
-3% -$15.3K
QTWO icon
110
Q2 Holdings
QTWO
$4B
$558K 0.17%
6,995
BIIB icon
111
Biogen
BIIB
$30.4B
$558K 0.16%
2,877
-52
-2% -$10.9K
ELV icon
112
Elevance Health
ELV
$85.2B
$553K 0.16%
1,064
-19
-2% -$10.2K
VZ icon
113
Verizon
VZ
$197B
$551K 0.16%
12,263
-318
-3% -$13.3K
LNC icon
114
Lincoln National
LNC
$8.6B
$527K 0.16%
16,709
-412
-2% -$12.8K
COP icon
115
ConocoPhillips
COP
$151B
$526K 0.16%
4,993
-91
-2% -$9.99K
HALO icon
116
Halozyme
HALO
$11.7B
$523K 0.15%
9,142
BDX icon
117
Becton Dickinson
BDX
$49.1B
$520K 0.15%
2,156
-38
-2% -$8.91K
BIO icon
118
Bio-Rad Laboratories Class A
BIO
$9.43B
$509K 0.15%
1,521
-28
-2% -$8.89K
MAR icon
119
Marriott International
MAR
$91.5B
$505K 0.15%
2,030
-37
-2% -$8.62K
WFC icon
120
Wells Fargo
WFC
$265B
$498K 0.15%
8,817
-159
-2% -$8.99K
PFE icon
121
Pfizer
PFE
$151B
$496K 0.15%
17,156
-654
-4% -$19.1K
NOC icon
122
Northrop Grumman
NOC
$81.8B
$496K 0.15%
939
-17
-2% -$8.32K
UBER icon
123
Uber
UBER
$160B
$489K 0.14%
6,502
-279
-4% -$19.6K
BCO icon
124
Brink's
BCO
$4.67B
$488K 0.14%
4,221
REGN icon
125
Regeneron Pharmaceuticals
REGN
$83.1B
$483K 0.14%
459
-9
-2% -$10K

Similar funds

CIM Investment Management's Q3 2024 Portfolio in Review

As of Q3 2024, CIM Investment Management held 267 positions worth $338M, up 4.3% from $324M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

CIM Investment Management's Q3 2024 filing shows 12 new, 5 increased, 159 reduced and 13 closed positions. Its largest new stake was Newmont: 19,333 shares worth $1.03M. The largest sale was Tyler Technologies, an estimated $1.07M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • CIM Investment Management's largest Q3 2024 buy was Newmont: 19,333 shares worth $1.03M.
  • CIM Investment Management added most to iShares Core S&P 500 ETF in Q3 2024, an estimated $1.2M increase.
  • CIM Investment Management's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $536K.
  • CIM Investment Management fully exited Tyler Technologies in Q3 2024, selling an estimated $1.07M.
  • CIM Investment Management's ten largest holdings make up 48% of its $338M portfolio in Q3 2024.
  • CIM Investment Management opened 12 new positions and closed 13 in Q3 2024.
  • CIM Investment Management's portfolio value rose 4.3% quarter-over-quarter to $338M.

Based on CIM Investment Management's 13F filing for Q3 2024, filed 25 Nov 2024.